
Bronchial asthma remains one of the most prevalent and socially significant chronic respiratory diseases worldwide. According to the World Health Organization (WHO), asthma affects approximately 262 million people and caused over 461,000 deaths in 2019 alone. Despite advancements in medical technology, pharmacotherapy, and improved global access to healthcare, bronchial asthma continues to represent a major public health burden, particularly due to its chronic nature, rising incidence in both developed and developing countries, and the substantial economic impact of its management.
Bronchial asthma, airway inflammation, GINA guidelines, asthma exacerbation, phenotype, inhaled corticosteroids, biologic therapy, respiratory diseases, chronic illness, public health.
Bronchial asthma, airway inflammation, GINA guidelines, asthma exacerbation, phenotype, inhaled corticosteroids, biologic therapy, respiratory diseases, chronic illness, public health.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
